Anti-CD325 Purified

Anti-CD325 Purified
Regulatory status
RUO
Antigen
CD325
Clone
8C11
Format
Purified
Reactivity
Mouse, Human
Variant
0.1 mg
11-849-C100
In stock
140.00 USD
Variant
0.1 mg
11-261-C100
In stock
140.00 USD
Product details
Description
Images
References
Isotype
Mouse IgG1 kappa
Specificity
The mouse monoclonal antibody 8C11 recognizes an extracellular epitope of CD325 (N-cadherin), a transmembrane protein associated with actin cytoskeleton system, which is expressed mainly by neurons, osteoblasts, endothelial cells, and stem cells.
Application details
Flow cytometry: Recommended dilution: 1-4 μg/ml.
Reactivity
Mouse, Human
Immunogen
bacterially expressed extracellular domain of human CD325
Concentration
1 mg/ml
Preparation
Purified by protein-A affinity chromatography.
Formulation
Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
Storage and handling
Store at 2-8°C. Do not freeze.
Exbio licence note
The product is intended For Research Use Only. Diagnostic or therapeutic applications are strictly forbidden. Products shall not be used for resale or transfer to third parties either as a stand-alone product or as a manufacture component of another product without written consent of EXBIO Praha, a.s. EXBIO Praha, a.s. will not be held responsible for patent infringement or any other violations of intellectual property rights that may occur with the use of the products. Orders for all products are accepted subject to the Term and Conditions available at www.exbio.cz. EXBIO, EXBIO Logo, and all other trademarks are property of EXBIO Praha, a.s.
Other names
N-Cadherin, cadherin 2, CDHM, CDH2
Antigen description
CD325 (N-cadherin) is a type I transmembrane protein, which forms a complex with catenins, that is linked to the actin cytoskeleton. This complex is important in synapses and for functional plasticity of neurons, and is also essential for embryonic development. Decreased CD325 cleavage caused by mutations in presenilin 1 is associated with Alzheimer´s disease. Besides nervous system, CD325 is expressed on the surface of malignant T cells, and increases their adhesion to epithelia, as well as their ability to invade and metastasize to inflammatory sites.
Entrez Gene ID 1000
UniProt ID P19022
11-849_FC_Histogram
Separation of HeLa cells stained using anti-CD325 (8C11) purified antibody (concentration in sample 3,3 μg/ml, GAM APC, red-filled) from HeLa cells stained using mouse IgG1 isotype control (MOPC-21) antibody (concentration in sample 3,3 μg/ml, same as CD325 purified antibody concentration, GAM APC, black-dashed) in flow cytometry analysis (surface staining).

Product specific references:

Navarro P, Ruco L, Dejana E: Differential localization of VE- and N-cadherins in human endothelial cells: VE-cadherin competes with N-cadherin for junctional localization. J Cell Biol. 1998 Mar 23;140(6):1475-84.
PubMed
Kim JB, Islam S, Kim YJ, Prudoff RS, Sass KM, Wheelock MJ, Johnson KR: N-Cadherin extracellular repeat 4 mediates epithelial to mesenchymal transition and increased motility. J Cell Biol. 2000 Dec 11;151(6):1193-206.
PubMed
Puch S, Armeanu S, Kibler C, Johnson KR, Müller CA, Wheelock MJ, Klein G: N-cadherin is developmentally regulated and functionally involved in early hematopoietic cell differentiation. J Cell Sci. 2001 Apr;114(Pt 8):1567-77.
PubMed
Wahl JK, Kim YJ, Cullen JM, Johnson KR, Wheelock MJ: N-cadherin-catenin complexes form prior to cleavage of the proregion and transport to the plasma membrane. J Biol Chem. 2003 May 9;278(19):17269-76.
PubMed
Jaggi M, Wheelock MJ, Johnson KR: Differential displacement of classical cadherins by VE-cadherin. Cell Commun Adhes. 2002 Mar-Apr;9(2):103-15.
PubMed
Variant
0.1 mg
11-849-C100
In stock
140.00 USD
Variant
0.1 mg
11-261-C100
In stock
140.00 USD

Related products

-134%
Reg. statusCE IVD
ApplicationFC
100 ml
200.00 USD
-134%
Reg. statusCE IVD
ApplicationFC
100 ml
60.00 USD
-134%
Reg. statusRUO
ApplicationFC
100 ml
50.00 USD
-134%
CloneMOPC-21
Reg. statusRUO
0.1 mg
105.00 USD